We are live on ! Find out more
BJCT

BIOJECT MEDICAL TECHS INC
BJCT

Delisted

BJCT was delisted on the 22nd of July, 2008.

Back to rankings

2 hedge funds and large institutions have $18K invested in BIOJECT MEDICAL TECHS INC in 2014 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $15K → $18K (+$3K)

0% more funds holding

Funds holding: 2 → 2 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FBA
1
Front Barnett Associates
Illinois
$17K – – –
Ameriprise
2
Ameriprise
Minnesota
$1K – – –

BJCT Hedge Fund Activity: Q2 2014 in Review

2 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in BIOJECT MEDICAL TECHS INC (BJCT) for Q2 2014, worth a combined $18K — up 20% from $15K a quarter earlier.

Fund positioning in BJCT was balanced in Q2 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held BIOJECT MEDICAL TECHS INC (BJCT) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $18K of BIOJECT MEDICAL TECHS INC stock for Q2 2014, up 20% quarter-over-quarter.
  • 0 funds opened new BIOJECT MEDICAL TECHS INC positions in Q2 2014 and 0 closed out.

Based on aggregated 13F filings for Q2 2014.